{"id":1058,"date":"2019-03-09T11:31:07","date_gmt":"2019-03-09T11:31:07","guid":{"rendered":"https:\/\/www.innopharmaeducation.com\/?p=1058"},"modified":"2024-11-12T05:33:13","modified_gmt":"2024-11-12T05:33:13","slug":"innopharma-technology-horizon-2020-funding","status":"publish","type":"post","link":"https:\/\/www.innopharmaeducation.com\/innopharma-news-and-events\/news\/innopharma-technology-horizon-2020-funding","title":{"rendered":"Innopharma Technology &amp; Horizon 2020 Funding"},"content":{"rendered":"\n<p>On the 1st March 2019, Innopharma Technology formally commenced an R&amp;D project called SmartCrys. The SmartCrys project will apply Pharma 4.0 technologies and know-how to address key challenges of the pharmaceutical industry related to the manufacturing of high-quality active drug or active pharmaceutical ingredients (APIs) which are formed through crystallisation processes. The project is 24 months in duration and is EU funded (\u20ac2.1m) through Horizon 2020 SME instrument. This is a competitive funding process with submitted proposals achieving &lt;5% success which is a testament in itself to the recognition the EU gave to the critical impact of the project.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>On the 1st March 2019, Innopharma Technology formally commenced an R&amp;D project called SmartCrys. The SmartCrys project will apply Pharma 4.0 technologies and know-how to address key challenges of the pharmaceutical industry related to the manufacturing of high-quality active drug or active pharmaceutical ingredients (APIs) which are formed through crystallisation processes. The project is 24 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1210,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[43],"tags":[],"class_list":["post-1058","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/www.innopharmaeducation.com\/wp-json\/wp\/v2\/posts\/1058","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.innopharmaeducation.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.innopharmaeducation.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.innopharmaeducation.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.innopharmaeducation.com\/wp-json\/wp\/v2\/comments?post=1058"}],"version-history":[{"count":1,"href":"https:\/\/www.innopharmaeducation.com\/wp-json\/wp\/v2\/posts\/1058\/revisions"}],"predecessor-version":[{"id":1059,"href":"https:\/\/www.innopharmaeducation.com\/wp-json\/wp\/v2\/posts\/1058\/revisions\/1059"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.innopharmaeducation.com\/wp-json\/wp\/v2\/media\/1210"}],"wp:attachment":[{"href":"https:\/\/www.innopharmaeducation.com\/wp-json\/wp\/v2\/media?parent=1058"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.innopharmaeducation.com\/wp-json\/wp\/v2\/categories?post=1058"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.innopharmaeducation.com\/wp-json\/wp\/v2\/tags?post=1058"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}